Dual-Receptor Precision for Advanced Weight Management Research

🔬 Product Overview

Cagrilintide is a cutting-edge long-acting amylin analogue developed by Novo Nordisk This dual amylin and calcitonin receptor agonist offers a novel mechanism of action for weight management, providing researchers with a potent tool for metabolic health studies.

🚀 Key Benefits

• *Dual Receptor Activation: Simultaneously targets amylin and calcitonin receptors to regulate appetite, enhance satiety, and modulate glucose metabolism.
• *Clinically Proven Efficacy: Clinical studies have demonstrated that Cagrilintide leads to clinically significant, dose-dependent weight loss, with greater reductions observed at higher doses.
• *Enhanced Metabolic Health: Treatment with Cagrilintide has been associated with significant reductions in body weight and improved metabolic parameters.
• *Cost-Effective Research Tool: The 10mg vial offers a more affordable option for extended research protocols, reducing the cost per milligram compared to higher doses.

🧪 Composition

• *Active Ingredient: Cagrilintide
• *Concentration: 10mg per vial.
• *Form: Lyophilized peptide powder

📦 Usage & Storage

• Intended Use: For research purposes only
• Storage: Store lyophilized powder in a cool, dry place. After reconstitution, refrigerate at 2–8°C and use within the designated study period.

🛒 Order your 10mg Cagrilintide today for £300.00